EMA
safety_alert
· 2007-03-30
European Medicines Agency recommends restricted use and strengthened warnings for Ketek
Summary
EMA recommends restricted use and stronger warnings for Ketek (telithromycin) due to safety concerns, limiting indications and enhancing risk communication.
Upgrade for the full analysis, importance score, and drug timeline.